Drugs / Allogeneic adipose derived stem/stromal cells
Allogeneic adipose derived stem/stromal cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03874572 | Mar 2019 → Jun 2020 | oropharynx cancer, salivary gland disorder | Rigshospitalet, Denmark | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic adipose derived stem/stromal cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03874572 ↗ |
| Modality | Cell therapy | “allogeneic adipose derived stem/stromal cells” NCT03874572 ↗ |
| Route | Other | “intraglandular injections” NCT03874572 ↗ |